Latest Monvia (ASX:MNV) News

AI infrastructure deals drove the week’s biggest technology share moves, led by X2M’s 350% surge and fresh data-centre contracts for DXN. Strong company results were mixed with investor reactions, as profitable growth lifted several stocks while losses, legal issues and weak outlooks punished others.

Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.

Nanoveu led the week after live drone trials, while Gratifii slumped on deal changes and X2M dropped after a discounted capital raising. Across the tech board, buyers backed real revenue, cash receipts and contract wins, but punished dilution, legal noise and weak post-gap trading.

Monvia Limited, an Australian SaaS provider for life insurers, is seeking to raise $17.5 million via an IPO on the ASX. The funds will support redemption of preference shares and fuel growth in existing and new markets.